Abstract: A cracking process for a reaction distillation of chlorosilane slurry includes feeding a chlorosilane slurry into a phase separator, drying a solid phase, feeding a chlorosilane polymer into a plate distillation column, returning kettle materials of the plate distillation column, and dividing a material produced from a top of the column. The process adopts an ionic liquid catalyst, which is environmentally friendly and reusable. The cracking and distillation of chlorosilane polymer are carried out simultaneously to shorten the time and increase the utilization rate of raw materials, which can reduce energy consumption and save costs and facilitate industrial production. A plate column is used as a distillation column, in which the two phases of the gas and liquid are sufficiently contacted. Therefore, the transfer of mass and heat is good, the production capacity is good, and the tower is not easily blocked, thereby making it easy to clean.

Abstract: A class of ketoamide-based compounds, in particular, a ketoarnide-based compound as represented by general formula A is provided. The ketoamide compound may be used as a 2019 novel coronavirus (2019-nCov) 3 CL protease inhibitor and/or human cathepsin L inhibitor, and/or may be used in the preparation of a medicament for treating and/or preventing and relieving respiratory tract infection, pneumonia and other related diseases caused by 2019 novel coronavirus infection. Pharmaceutical compositions of the class of compounds, pharmaceutical salts, enantiomeric forms, diastereoisomers and racemic compounds thereof in the preparation of a medicament for treating and/or preventing and relieving respiratory tract infections and other related diseases caused by the 2019 novel coronavirus infection are also provided.

Abstract: A multi-beam laser radar includes a rotating prism, a rotating mechanism, and two transceiver modules. The rotating prism includes at least three side surfaces around a scanning rotation axis of the rotating prism; at least two of the at least three side surfaces are reflecting surfaces, and in all reflecting surfaces, included angles between at least two of the reflecting surfaces and the scanning rotation axis of the rotating prism are unequal. The rotating mechanism drives the rotating prism to rotate around the scanning rotation axis. The two transceiver modules are positioned at two sides of the rotating prism respectively and asymmetrical with respect to the scanning rotation axis, an included angle formed by laser emitting surfaces of the two transceiver modules is less than 180 degrees, such that scanning fields of view in at least two directions are formed when the rotating prism rotates around the scanning rotation axis.

Abstract: A prism for a multi-beam lidar includes a top surface, a bottom surface, and at least three side surfaces positioned between the top surface and the bottom surface, at least two of the at least three side surfaces each include an emission region and a receiving region; the receiving region is positioned between the emission region and the top surface; in a direction from the top surface to the bottom surface, the emission region includes at least two reflecting surfaces positioned successively, and included angles between the at least two reflecting surfaces and the bottom surface are different from each other.

Abstract: In some aspects, the disclosure relates to methods and compositions for delivery of proteins into mammalian cells. In some embodiments, the disclosure provides a genetically engineered bacterium that may be useful for delivery of proteins into mammalian cells. In some aspects, the disclosure relates to improved methods of bacterially-mediated protein delivery.

Abstract: In some aspects, the disclosure relates to methods and compositions for delivery of proteins into mammalian cells. In some embodiments, the disclosure provides a genetically engineered bacterium that may be useful for delivery of proteins into mammalian cells. In some aspects, the disclosure relates to improved methods of bacterially-mediated protein delivery.

Abstract: Provided are a pteridine ketone derivative used as an EGFR, BLK, and FLT3 inhibitor and applications thereof. Specifically, provided are a compound of the following formula I, a pharmaceutical composition containing the compound of the formula I, and use of compound in preparing medicine for treating diseases mediated by EGFR, BLK, or FLT3 or inhibiting EGFR, BLK, and FLT3.

Abstract: Provided are a pteridine ketone derivative used as an EGFR, BLK, and FLT3 inhibitor and applications thereof. Specifically, provided are a compound of the following formula I, a pharmaceutical composition containing the compound of the formula I, and use of compound in preparing medicine for treating diseases mediated by EGFR, BLK, or FLT3 or inhibiting EGFR, BLK, and FLT3.